Pascal Touchon is Senior Vice President, Global Head Cell & Gene and member of the Oncology Executive Committee. In this role, Pascal is responsible for leading a cross- functional and cross-divisional team in Cell & Gene Therapies, reporting to Elizabeth Barrett, CEO of Novartis Oncology. His responsibilities cover clinical development, manufacturing, medical affairs, commercial activities and the development & execution of Novartis strategy in Cell & Gene Therapies in oncology.
Prior to this Pascal was Senior Vice President and Global Head Oncology Strategy & Business Development. Pascal was responsible for Novartis Oncology early commercial strategy, portfolio management, BD&L, external collaborations, alliance management, disruptive technologies, Therapeutic Integrity & Established Medicines as well as global business activities in Cell & Gene Therapies. He was also a Board member of Genoptix and then Navigate Biopharma Services Inc., a Novartis company dedicated to oncology clinical trials diagnostics, whose President was reporting to Pascal.
Prior to joining Novartis, Pascal was Senior Executive Vice President and Head of Business Development and Licensing for Servier, a private research-based pharmaceutical company, where he led the sourcing, evaluation, negotiation and closing of numerous partnerships with biotechs, pharmaceutical companies and academic institutions.
Prior to joining Novartis, Pascal has held positions in Research, Marketing and Sales, General Management and Business Development at various companies including Sanofi, Virbac, Glaxo, Glaxo-Wellcome and Servier. He has extensive international experience in leading marketing and commercial operations and as General Manager in France, Central & Eastern Europe, Northern Europe, Asia, Australia, Canada, and South Africa.
Education and Training
Pascal holds a Doctorate in Veterinary Medicine from Paul Sabatier University (Toulouse, France), a Diplôme d'Etudes Superieures Specialisees (DESS) in Management from Institut d’Administration des Entreprises (Toulouse, France) and an MBA from INSEAD (Fontainebleau, France).
There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October